First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

•Patients with VTE-NC can be treated for three months with LMWH.•Meta-analysis which compared LMWH versus AVKs, not confirm s differences in VTE recurrence, bleeding and mortality.•In this report, the largest number of patients with VTE-NC, is included.•In RIETE population with VTE-NC, patients with LMWH alone had more episodes of recurrence, major bleeding and death, than AVKs.